February 25, 2011 (Updated February 28, 2011) (Silver Spring, Maryland) — The Food and Drug Administration (FDA) today approved a new angiotensin-receptor blocker (ARB), azilsartan medoxomil (Edarbi, ...

Learn everything you need to know about Azilsartan Medoxomil-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

May 24, 2011 (New York, New York) — The use of the combination therapy azilsartan medoxomil (Edarbi, Takeda Pharmaceuticals) and chlorthalidone resulted in a more effective reduction in systolic blood ...

Active ingredient: Azilsartan medoxomil 40 mg, 80 mg; tabs. Indication: Hypertension. May be used alone or in combination with other antihypertensive agents. The actual drug substance is the potassium ...

Up-to-date prescription details regarding Azilsartan Medoxomil and Chlorthalidone are provided here. Understand it's uses, recommended dosages, its indications, how to take, when to take, when not to ...

The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to U.S. patients. According to the FDA, ...

Edarbi (azilsartan) is a high blood pressure medication that may cause side effects such as nausea and vomiting, fatigue, weakness, and cough. Some people may experience more significant side effects ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the US Food and Drug Administration (US FDA) to market Azilsartan Medoxomil and Chlorthalidone tablets, 40 mg/12.5 mg and 40 ...

Mumbai, 16th May, 2017 : Mankind Pharma, a quality driven pharmaceutical company in India launches Anti-Hypertensive-drug Zolahart (Azilsartan), at an affordable price of Rs 7.50 per tablet. Aiming at ...

Takeda says it has completed settlements with six out of eight defendants in patent infringement litigation concerning possible generic versions of the Japanese drugmaker’s diabetes blockbuster Actos ...